Sarcoidosis-Immunopathogenetic Concepts

ABSTRACT

Sarcoidosis is a chronic granulomatous disorder characterized by an accumulation of activated lymphocytes, predominantly T helper cells, expressing the Th1 phenotype and macrophages at sites of disease activity. Although the cause of sarcoidosis has not been elucidated, several lines of evidence suggest that granuloma formation results from exposure to one or more antigens, eliciting a T lymphocyte response. The induction and evolution of granuloma formation results from a complex interplay between diverse cell types, cytokines, and chemokines. Genetic polymorphisms may influence the clinical expression of the granuloma formation and disease outcome. This article discusses in depth the key cellular elements and signals that generate and orchestrate the sarcoid granulomatous response. The precise factors inciting the sarcoid granulomatous response have not yet been identified, but chronic exposure to microbial agents, their products, or inorganic substances may be important in the pathogenesis.

Sarcoidosis - granuloma - immunopathogenesis - T cells - alveolar macrophages - chemokines - cytokines

REFERENCES

• 1 Schurmann M. Genetics of sarcoidosis.  Semin Respir Crit Care Med. 2003;  24 213-222
• 2 Rybicki B A, Hirst K, Iyengar S K et al.. A sarcoidosis genetic linkage consortium: the sarcoidosis genetic analysis (SAGA) study.  Sarcoidosis Vasc Diffuse Lung Dis. 2005;  22 115-122
• 3 du Bois R M, Kirby M, Balbi B, Saltini C, Crystal R G. T-lymphocytes that accumulate in the lung in sarcoidosis have evidence of recent stimulation of the T-cell antigen receptor.  Am Rev Respir Dis. 1992;  145 1205-1211
• 4 Müller-Quernheim J, Saltini C, Sondermeyer P, Crystal R G. Compartmentalized activation of the interleukin-2 gene by lung T-lymphocytes in active pulmonary sarcoidosis.  J Immunol. 1986;  137 3475-3483
• 5 Devergne O, Emilie D, Peuchmaur M et al.. Production of cytokines in sarcoid lymph nodes: preferential expression of interleukin-1 beta and interferon-gamma genes.  Hum Pathol. 1992;  23 317-323
• 6 Müller-Quernheim J, Krönke M, Strausz J, Schykowski M, Ferlinz R. Interleukin-2 receptor gene expression by bronchoalveolar lavage lymphocytes in pulmonary sarcoidosis.  Am Rev Respir Dis. 1989;  140 82-88
• 7 Paine R, Mody C H, Chawis A et al.. Alveolar epithelial cells block lymphocyte proliferation in vitro without inhibiting activation.  Am J Respir Cell Mol Biol. 1991;  5 221-229
• 8 Ziegenhagen M W, Rothe M E, Schlaak M, Müller-Quernheim J. Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis.  Eur Respir J. 2003;  21 407-413
• 9 Grutters J C, Fellrath J M, Mulder L et al.. Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation.  Chest. 2003;  124 186-195
• 10 Rothkrantz-Kos S, van Dieijen-Visser M P, Mulder P G, Drent M. Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis.  Clin Chem. 2003;  49 1510-1517
• 11 Capelli A, Di Stefano A, Lusuardi M, Gnemmi I, Donner C F. Increased macrophage inflammatory protein-1alpha and macrophage inflammatory protein-1beta levels in bronchoalveolar lavage fluid of patients affected by different stages of pulmonary sarcoidosis.  Am J Respir Crit Care Med. 2002;  165 236-241
• 12 Ziegenhagen M W, Schrum S, Zissel G et al.. Increased expression of proinflammatory chemokines in bronchoalveolar lavage cells of patients with progressing idiopathic pulmonary fibrosis and sarcoidosis.  J Investig Med. 1998;  46 223-231
• 13 Richter E, Kataria Y P, Zissel G et al.. Analysis of the Kveim-Siltzbach test reagent for bacterial DNA.  Am J Respir Crit Care Med. 1999;  159 1981-1984
• 14 Holter J F, Park H K, Sjoerdsma K W, Kataria Y P. Nonviable autologous bronchoalveolar lavage cell preparations induce intradermal epithelioid cell granulomas in sarcoidosis patients.  Am Rev Respir Dis. 1992;  145 864-871
• 15 Klein J T, Horn T D, Forman J D et al.. Selection of oligoclonal Vβ-specific T cells in the intradermal response to Kveim-Siltzbach reagent in individuals with sarcoidosis.  J Immunol. 1995;  154 1450-1460
• 16 Silver R F, Crystal R G, Moller D R. Limited heterogeneity of biased T-cell receptor V beta gene usage in lung but not blood T cells in active pulmonary sarcoidosis.  Immunology. 1996;  88 516-523
• 17 Zissel G, Bäumer I, Fleischer B, Schlaak M, Müller-Quernheim J. TCR Vβ families in T cell clones from sarcoid lung parenchyma, BAL, and blood.  Am J Respir Crit Care Med. 1997;  156 1593-1600
• 18 Bäumer I, Zissel G, Schlaak M, Müller-Quernheim J. Th1/Th2 cell distribution in pulmonary sarcoidosis.  Am J Respir Cell Mol Biol. 1997;  16 171-177
• 19 Grunewald J, Wahlstrom J, Berlin M et al.. Lung restricted T cell receptor AV2S3 + CD4 + T cell expansions in sarcoidosis patients with a shared HLA-DRbeta chain conformation.  Thorax. 2002;  57 348-352
• 20 Katchar K, Wahlstrom J, Eklund A, Grunewald J. Highly activated T-cell receptor AV2S3( + ) CD4( + ) lung T-cell expansions in pulmonary sarcoidosis.  Am J Respir Crit Care Med. 2001;  163 1540-1545
• 21 Grunewald J, Berlin M, Olerup O, Eklund A. Lung T-helper cells expressing T-cell receptor AV2S3 associate with clinical features of pulmonary sarcoidosis.  Am J Respir Crit Care Med. 2000;  161(3 Pt 1) 814-818
• 22 Song Z, Marzilli L, Greenlee B M et al.. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis.  J Exp Med. 2005;  201 755-767
• 23 Miyara M, Amoura Z, Parizot C et al.. The immune paradox of sarcoidosis and regulatory T cells.  J Exp Med. 2006;  203 359-370
• 24 Zissel G, Baumer I, Schlaak M, Müller-Quernheim J. In vitro release of interleukin-15 by broncho-alveolar lavage cells and peripheral blood mononuclear cells from patients with different lung diseases.  Eur Cytokine Netw. 2000;  11 105-112
• 25 Stridh H, Planck A, Gigliotti D, Eklund A, Grunewald J. Apoptosis resistant bronchoalveolar lavage (BAL) fluid lymphocytes in sarcoidosis.  Thorax. 2002;  57 897-901
• 26 Dustin M L. Coordination of T cell activation and migration through formation of the immunological synapse.  Ann NY Acad Sci. 2003;  987 51-59
• 27 Yarbrough W C, Wilkes D S, Weissler J. Human alveolar macrophages inhibit receptor mediated increases in intracellular calcium concentration in lymphocytes.  Am J Respir Cell Mol Biol. 1991;  5 411-415
• 28 Ettensohn D B, Lalor P A, Roberts N J. Human alveolar macrophage regulation of lymphocyte proliferation.  Am Rev Respir Dis. 1986;  133 1091-1096
• 29 Lem V M, Lipscomb M F, Weissler J C et al.. Bronchoalveolar cells from sarcoid patients demonstrate enhanced antigen presentation.  J Immunol. 1985;  135 1766-1771
• 30 Venet A, Hance A, Saltini C, Robinson B WS, Crystal R G. Enhanced alveolar macrophage-mediated antigen-induced T lymphocyte proliferation in sarcoidosis.  J Clin Invest. 1985;  75 293-301
• 31 Ina Y, Takada K, Yamamoto M, Morishita M, Miyashi A. Antigen presenting capacity in patients with sarcoidosis.  Chest. 1990;  98 911-916
• 32 Zissel G, Ernst M, Schlaak M, Müller-Quernheim J. Accessory function of alveolar macrophages from patients with sarcoidosis and other granulomatous and non-granulomatous lung diseases.  J Investig Med. 1997;  45 75-86
• 33 Poulter L W. Changes in lung macrophages during disease.  FEMS Microbiol Immunol. 1990;  2 327-331
• 34 Rossi G A, Zocchi E, Sacco O et al.. Alveolar macrophage stimulation of T-cell proliferation in autologous mixed lymphocyte reactions: role of HLA-DR antigens.  Am Rev Respir Dis. 1986;  133 78-82
• 35 Berlin M, Fogdell-Hahn A, Olerup O, Eklund A, Grunewald J. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis.  Am J Respir Crit Care Med. 1997;  156 1601-1605
• 36 Martinetti M, Luisetti M, Cuccia M. HLA and sarcoidosis: new pathogenetic insights.  Sarcoidosis Vasc Diffuse Lung Dis. 2002;  19 83-95
• 37 Schurmann M, Bein G, Kirsten D et al.. HLA-DQB1 and HLA-DPB1 genotypes in familial sarcoidosis.  Respir Med. 1998;  92 649-652
• 38 Hoshino T, Itoh K, Gouhara R et al.. Spontaneous production of various cytokines except IL-4 from CD4 + T cells in the affected organs of sarcoidosis patients.  Clin Exp Immunol. 1995;  102 399-405
• 39 Nicod L P, Songeon F, Isler P. Alveolar macrophages in sarcoidosis coexpress high levels of CD86 (B7.2), CD40, and CD30L.  Am J Respir Cell Mol Biol. 1997;  17 91-96
• 40 Kaneko Y, Kuwano K, Kunitake R et al.. Immunohistochemical localization of B7 costimulating molecules and major histocompatibility complex class II antigen in pulmonary sarcoidosis.  Respiration. 1999;  66 343-348
• 41 Agostini C, Trentin L, Perin A et al.. Regulation of alveolar macrophage-T cell interactions during Th1-type sarcoid inflammatory process.  Am J Physiol. 1999;  277(2 Pt 1) L240-L250
• 42 Zissel G, Ernst M, Schlaak M, Müller-Quernheim J. Pharmacological modulation of the IFNgamma-induced accessory function of alveolar macrophages and peripheral blood monocytes.  Inflamm Res. 1999;  48 662-668
• 43 Wahlström J, Berlin M, Skold C M et al.. Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis.  Thorax. 1999;  54 339-346
• 44 Nicod L P, El Habre F. Adhesion molecules on human lung dendritic cells and their role for T-cell activation.  Am J Respir Cell Mol Biol. 1992;  7 207-213
• 45 Nguyen T, Liu X K, Zhang Y, Dong C. BTNL2, a butyrophilin-like molecule that functions to inhibit T cell activation.  J Immunol. 2006;  176 7354-7360
• 46 Valentonyte R, Hampe J, Huse K et al.. Sarcoidosis is associated with a truncating splice site mutation in BTNL2.  Nat Genet. 2005;  37 357-364
• 47 Li Y, Wollnik B, Pabst S et al.. BTNL2 gene variant and sarcoidosis.  Thorax. 2006;  61 273-274
• 48 Rybicki B A, Walewski J L, Maliarik M J, Kian H, Iannuzzi M C. The BTNL2 gene and sarcoidosis susceptibility in African Americans and whites.  Am J Hum Genet. 2005;  77 491-499
• 49 Munro C S, Campbell D A, Du Bois R M et al.. Dendritic cells in cutaneous, lymph node and pulmonary lesions of sarcoidosis.  Scand J Immunol. 1987;  25 461-467
• 50 Gibejova A, Mrazek F, Subrtova D et al.. Expression of macrophage inflammatory protein-3{beta}/CCL19 in pulmonary sarcoidosis.  Am J Respir Crit Care Med. 2003;  167 1695-1703
• 51 Katchar K, Soderstrom K, Wahlstrom J, Eklund A, Grunewald J. Characterisation of natural killer cells and CD56 + T-cells in sarcoidosis patients.  Eur Respir J. 2005;  26 77-85
• 52 Robinson B W, Pinkston P, Crystal R G. Natural killer cells are present in the normal human lung but are functionally impotent.  J Clin Invest. 1984;  74 942-950
• 53 Müller-Quernheim J, Pfeiffer S, Männel D, Strausz J, Ferlinz R. Lung restricted activation of the alveolar macrophage / monocyte system in pulmonary sarcoidosis.  Am Rev Respir Dis. 1992;  145 187-192
• 54 Bachwich P R, Lynch J P, Larrick J W, Spengler M, Kunkel S L. Tumor necrosis factor production by human sarcoid alveolar macrophages.  Am J Pathol. 1986;  125 421-425
• 55 de Rochemonteix B, Dayer J, Junod A. Expression of m-RNA of interleukin-1a,b and tumor necrosis factor a in human alveolar macrophages from patients with pulmonary sarcoidosis and fibrosis.  Eur Respir J. 1990;  3 653-664
• 56 Baughman R P, Strohofer S A, Buchsbaum J, Lower E E. Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis.  J Lab Clin Med. 1990;  115 36-42
• 57 Zheng L, Teschler H, Guzman J et al.. Alveolar macrophage TNF-α release and BAL cell phenotypes in sarcoidosis.  Am J Respir Crit Care Med. 1995;  152 1061-1066
• 58 Fehrenbach H, Zissel G, Goldmann T et al.. Alveolar macrophages are the main source for tumour necrosis factor-alpha in patients with sarcoidosis.  Eur Respir J. 2003;  21 421-428
• 59 Hänsch H C, Smith D A, Mielke M E et al.. Mechanisms of granuloma formation in murine Mycobacterium avium infection: the contribution of CD4 + T cells.  Int Immunol. 1996;  8 1299-1310
• 60 Smith D, Hansch H, Bancroft G, Ehlers S. T-cell-independent granuloma formation in response to Mycobacterium avium: role of tumour necrosis factor-alpha and interferon-gamma.  Immunology. 1997;  92 413-421
• 61 Seitzer U, Swider C, Stuber F et al.. Tumour necrosis factor alpha promoter gene polymorphism in sarcoidosis.  Cytokine. 1997;  9 787-790
• 62 Mrazek F, Holla L I, Hutyrova B et al.. Association of tumour necrosis factor-alpha, lymphotoxin-alpha and HLA-DRB1 gene polymorphisms with Lofgren's syndrome in Czech patients with sarcoidosis.  Tissue Antigens. 2005;  65 163-171
• 63 Somoskövi A, Zissel G, Seitzer U et al.. Polymorphisms at position -308 in the promoter region of the TNF-α and in the first intron of the TNF-β genes and spontaneous and lipopolysaccharide-induced TNF-α release in sarcoidosis.  Cytokine. 1999;  11 882-887
• 64 Dai H, Guzman J, Costabel U. Increased expression of apoptosis signalling receptors by alveolar macrophages in sarcoidosis.  Eur Respir J. 1999;  13 1451-1454
• 65 Kieszko R, Krawczyk P, Chocholska S et al.. Tumor necrosis factor receptors (TNFRs) on T lymphocytes and soluble TNFRs in different clinical courses of sarcoidosis.  Respir Med. 2006;  101 645
• 66 Dai H, Guzman J, Chen B, Costabel U. Production of soluble tumor necrosis factor receptors and tumor necrosis factor-alpha by alveolar macrophages in sarcoidosis and extrinsic allergic alveolitis.  Chest. 2005;  127 251-256
• 67 Ziegenhagen M W, Benner U K, Zissel G et al.. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers.  Am J Respir Crit Care Med. 1997;  156 1586-1592
• 68 Hino T, Nakamura H, Shibata Y et al.. Elevated levels of type II soluble tumor necrosis factor receptors in the bronchoalveolar lavage fluids of patients with sarcoidosis.  Lung. 1997;  175 187-193
• 69 Agyekum S, Church A, Sohail M et al.. Expression of lymphotoxin-beta (LT-beta) in chronic inflammatory conditions.  J Pathol. 2003;  199 115-121
• 70 Bergeron A, Bonay M, Kambouchner M et al.. Cytokine patterns in tuberculous and sarcoid granulomas: correlations with histopathologic features of the granulomatous response.  J Immunol. 1997;  159 3034-3043
• 71 Magnusson C, Vaux D L. Signalling by CD95 and TNF receptors: not only life and death.  Immunol Cell Biol. 1999;  77 41-46
• 72 Ricci A, Mariotta S, Saltini C et al.. Neurotrophin system activation in bronchoalveolar lavage fluid immune cells in pulmonary sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis. 2005;  22 186-194
• 73 Ibelgauft H. COPE-Cytokines and Cells Online Pathfinder Encyclopaedia. 2006 http://www.copewithcytokines.de/
• 74 Kunitake R, Kuwano K, Miyazaki H et al.. Apoptosis in the course of granulomatous inflammation in pulmonary sarcoidosis.  Eur Respir J. 1999;  13 1329-1337
• 75 Agostini C, Zambello R, Sancetta R et al.. Expression of tumor necrosis factor-receptor superfamily members by lung T lymphocytes in interstitial lung diseases.  Am J Respir Crit Care Med. 1996;  153 1359-1367
• 76 Pechkovsky D V, Goldmann T, Vollmer E, Müller-Quernheim J, Zissel G. Interleukin-18 expression by alveolar epithelial cells type II in tuberculosis and sarcoidosis.  FEMS Immunol Med Microbiol. 2006;  46 30-38
• 77 Larousserie F, Pflanz S, Coulomb-L'Hermine A et al.. Expression of IL-27 in human Th1-associated granulomatous diseases.  J Pathol. 2004;  202 164-171
• 78 Shigehara K, Shijubo N, Ohmichi M et al.. IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs.  J Immunol. 2001;  166 642-649
• 79 Moller D R, Forman J D, Liu M C et al.. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis.  J Immunol. 1996;  156 4952-4960
• 80 Oliver S J, Kikuchi T, Krueger J G, Kaplan G. Thalidomide induces granuloma differentiation in sarcoid skin lesions associated with disease improvement.  Clin Immunol. 2002;  102 225-236
• 81 Moller D R, Wysocka M, Greenlee B M et al.. Inhibition of IL-12 production by thalidomide.  J Immunol. 1997;  159 5157-5161
• 82 Moller D R, Wysocka M, Greenlee B M et al.. Inhibition of human interleukin-12 production by pentoxifylline.  Immunology. 1997;  91 197-203
• 83 Lammas D A, De Heer E, Edgar J D et al.. Heterogeneity in the granulomatous response to mycobacterial infection in patients with defined genetic mutations in the interleukin 12-dependent interferon-gamma production pathway.  Int J Exp Pathol. 2002;  83 1-20
• 84 Kelly D M, Greene C M, Meachery G et al.. Endotoxin up-regulates interleukin-18: potential role for gram-negative colonization in sarcoidosis.  Am J Respir Crit Care Med. 2005;  172 1299-1307
• 85 Pinkston P, Bitterman P B, Crystal R G. Spontaneous release of interleukin-2 by lung T-lymphocytes in active pulmonary sarcoidosis.  N Engl J Med. 1983;  308 793-800
• 86 Agostini C, Trentin L, Facco M et al.. Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis.  J Immunol. 1996;  157 910-918
• 87 Muro S, Taha R, Tsicopoulos A et al.. Expression of IL-15 in inflammatory pulmonary diseases.  J Allergy Clin Immunol. 2001;  108 970-975
• 88 Müller-Quernheim J, Pfeifer S, Kienast K, Zissel G. Spontaneous interleukin 2 release of bronchoalveolar lavage cells in sarcoidosis is a codeterminator of prognosis.  Lung. 1996;  174 243-253
• 89 Fehervari Z, Yamaguchi T, Sakaguchi S. The dichotomous role of IL-2: tolerance versus immunity.  Trends Immunol. 2006;  27 109-111
• 90 Walker C, Bauer W, Braun R K et al.. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia.  Am J Respir Crit Care Med. 1994;  150 1038-1048
• 91 Wysoczanska B, Bogunia-Kubik K, Suchnicki K, Mlynarczewska A, Lange A. Combined association between IFN-gamma 3,3 homozygosity and DRB1*03 in Lofgren's syndrome patients.  Immunol Lett. 2004;  91 127-131
• 92 Zissel G, Schlaak J, Schlaak M, Müller-Quernheim J. Regulation of cytokine release by alveolar macrophages treated with interleukin-4, interleukin-10, or transforming growth factor beta.  European Cytokine Network. 1996;  7 59-66
• 93 Yamamoto H, Hirayama M, Genyea C, Kaplan J. TGFβ mediates natural suppressor activity of IL-2-activated lymphocytes.  J Immunol. 1994;  152 3842-3847
• 94 Limper A H, Colby T V, Sanders M S et al.. Immunohistochemical localization of transforming growth factor-β1 in the nonnecrotizing granulomas of pulmonary sarcoidosis.  Am J Respir Crit Care Med. 1994;  149 197-204
• 95 Zissel G, Homolka J, Schlaak J, Schlaak M, Müller-Quernheim J. Anti-inflammatory cytokine release by alveolar macrophages in pulmonary sarcoidosis.  Am J Respir Crit Care Med. 1996;  154 713-719
• 96 Bingisser R, Speich R, Zollinger A, Russi E, Frei K. Interleukin-10 secretion by alveolar macrophages and monocytes in sarcoidosis.  Respiration. 2000;  67 280-286
• 97 Salez F, Gosset P, Copin M C et al.. Transforming growth factor-beta1 in sarcoidosis.  Eur Respir J. 1998;  12 913-919
• 98 Muraközy G, Gaede K I, Zissel G, Schlaak M, Müller-Quernheim J. Analysis of gene polymorphisms in interleukin-10 and transforming growth factor-beta 1 in sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis. 2001;  18 165-199
• 99 Niimi T, Sato S, Sugiura Y et al.. Transforming growth factor-beta gene polymorphism in sarcoidosis and tuberculosis patients.  Int J Tuberc Lung Dis. 2002;  6 510-515
• 100 Kruit A, Grutters J C, Ruven H J et al.. Transforming growth factor-beta gene polymorphisms in sarcoidosis patients with and without fibrosis.  Chest. 2006;  129 1584-1591
• 101 Zissel G, Schlaak J, Schlaak M, Müller-Quernheim J. Regulation of cytokine release by alveolar macrophages treated with interleukin-4, interleukin-10, or transforming growth factor beta.  Eur Cytokine Netw. 1996;  7 59-66
• 102 Fiorentino D F, Zlotnik A, Mosmann T R, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages.  J Immunol. 1991;  147 3815-3822
• 103 Ding L, Linsley P S, Huang L Y, Germain R N, Shevach E M. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression.  J Immunol. 1993;  151 1224-1234
• 104 Minshall E M, Tsicopoulos A, Yasruel Z et al.. Cytokine mRNA gene expression in active and nonactive pulmonary sarcoidosis.  Eur Respir J. 1997;  10 2034-2039
• 105 Oltmanns U, Schmidt B, Hoernig S, Witt C, John M. Increased spontaneous interleukin-10 release from alveolar macrophages in active pulmonary sarcoidosis.  Exp Lung Res. 2003;  29 315-328
• 106 Lemaire I, Yang H. Colony stimulating factors induce alveolar macrophage differentiation and giant cell formation.  Ann NY Acad Sci. 1996;  796 173-181
• 107 Kreipe H, Radzun H J, Heidorn K et al.. Proliferation, macrophage colony-stimulating factor, and macrophage colony-stimulating factor-receptor expression of alveolar macrophages in active sarcoidosis.  Lab Invest. 1990;  62 697-703
• 108 Takeuchi M, Oh I K, Suzuki J et al.. Elevated serum levels of CXCL9/monokine induced by interferon-gamma and CXCL10/interferon-gamma-inducible protein-10 in ocular sarcoidosis.  Invest Ophthalmol Vis Sci. 2006;  47 1063-1068
• 109 Miotto D, Christodoulopoulos P, Olivenstein R et al.. Expression of IFN-gamma-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseases.  J Allergy Clin Immunol. 2001;  107 664-670
• 110 Kodama N, Yamaguchi E, Hizawa N et al.. Expression of RANTES by bronchoalveolar lavage cells in nonsmoking patients with interstitial lung diseases.  Am J Respir Cell Mol Biol. 1998;  18 526-531
• 111 Pignatti P, Brunetti G, Moretto D et al.. Role of the chemokine receptors CXCR3 and CCR4 in human pulmonary fibrosis.  Am J Respir Crit Care Med. 2006;  173 310-317
• 112 Katoh S, Fukushima K, Matsumoto N et al.. Accumulation of CXCR3-expressing eosinophils and increased concentration of its ligands (IP10 and Mig) in bronchoalveolar lavage fluid of patients with chronic eosinophilic pneumonia.  Int Arch Allergy Immunol. 2005;  137 229-235
• 113 Agostini C, Cassatella M, Zambello R et al.. Involvement of the IP-10 chemokine in sarcoid granulomatous reactions.  J Immunol. 1998;  161 6413-6420
• 114 Inoue T, Fujishima S, Ikeda E et al.. CCL22 and CCL17 in rat radiation pneumonitis and in human idiopathic pulmonary fibrosis.  Eur Respir J. 2004;  24 49-56
• 115 Mrazek F, Sekerova V, Drabek J et al.. Expression of the chemokine PARC mRNA in bronchoalveolar cells of patients with sarcoidosis.  Immunol Lett. 2002;  84 17-22
• 116 Prasse A, Pechkovsky D V, Toews G B et al.. A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18.  Am J Respir Crit Care Med. 2006;  173 781-792
• 117 Petrek M, Kolek V, Szotkowska J, du Bois R M. CC and C chemokine expression in pulmonary sarcoidosis.  Eur Respir J. 2002;  20 1206-1212
• 118 Sugiyama Y, Kasahara T, Mukaida N, Matsushima K, Kitamura S. Chemokines in the bronchoalveolar lavage fluid of patients with sarcoidosis.  Intern Med. 1997;  36 856-860
• 119 Iida K, Kadota J, Kawakami K et al.. Analysis of T cell subsets and beta chemokines in patients with pulmonary sarcoidosis.  Thorax. 1997;  52 431-437
• 120 Oshima M, Maeda A, Ishioka S, Hiyama K, Yamakido M. Expression of C-C chemokines in bronchoalveolar lavage cells from patients with granulomatous lung diseases.  Lung. 1999;  177 229-240
• 121 Petrek M, Pantelidis P, Southcott A M et al.. The source and role of RANTES in interstitial lung disease.  Eur Respir J. 1997;  10 1207-1216
• 122 Ziegenhagen M W, Zabel P, Zissel G, Schlaak M, Müller-Quernheim J. Serum level of interleukin 8 is elevated in idiopathic pulmonary fibrosis and indicates disease activity.  Am J Respir Crit Care Med. 1998;  157(3 Pt 1) 762-768
• 123 Car B D, Meloni F, Luisetti M et al.. Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis.  Am J Respir Crit Care Med. 1994;  149 655-659
• 124 Agostini C, Facco M, Siviero M et al.. CXC chemokines IP-10 and mig expression and direct migration of pulmonary CD8 + /CXCR3 + T cells in the lungs of patients with HIV infection and T-cell alveolitis.  Am J Respir Crit Care Med. 2000;  162(4 Pt 1) 1466-1473
• 125 Salmeri F M, Sofo V, Ando F G et al.. Imbalance of serum cytokine network in sarcoid patients: index of sarcoidosis relapse?.  Sarcoidosis Vasc Diffuse Lung Dis. 2003;  20 53-61
• 126 Khanna D, Liebling M R, Louie J S. Etanercept ameliorates sarcoidosis arthritis and skin disease.  J Rheumatol. 2003;  30 1864-1867
• 127 Baughman R P, Drent M, Kavuru M et al.. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.  Am J Respir Crit Care Med. 2006;  174 795-802
• 128 Ishige I, Usui Y, Takemura T, Eishi Y. Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis.  Lancet. 1999;  354 120-123
• 129 Eishi Y, Suga M, Ishige I et al.. Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis.  J Clin Microbiol. 2002;  40 198-204
• 130 Nakata Y, Ejiri T, Kishi T et al.. Alveolar lymphocyte proliferation induced by Propionibacterium acnes in sarcoidosis patients.  Acta Med Okayama. 1986;  40 257-264
• 131 Kalis C, Gumenscheimer M, Freudenberg N et al.. Requirement for TLR9 in the immunomodulatory activity of Propionibacterium acnes. .  J Immunol. 2005;  174 4295-4300
• 132 Ota M, Amakawa R, Uehira K et al.. Involvement of dendritic cells in sarcoidosis.  Thorax. 2004;  59 408-413